3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Polycystic Ovary Syndrome
2
Fatty Liver
2
Diabetes Mellitus
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Neoplasms
1
Lymphoma
1
Iron Overload
1
Hemoglobinopathies
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Fibrous Dysplasia, Polyostotic
1
Fibrous Dysplasia of Bone
1
Interventions
Psychiatric Rehabilitation
7
Flow Cytometry
6
Therapeutics
5
Surveys and Questionnaires
5
Microarray Analysis
5
Gene Expression Profiling
5
Vincristine
4
Polymerase Chain Reaction
4
Methotrexate
4
Daunorubicin
4
Cytogenetic Analysis
4
Amplified Fragment Length Polymorphism Analysis
4
ponatinib
3
fludarabine
3
Watchful Waiting
3
Prednisone
3
Observation
3
Mercaptopurine
3
Interviews as Topic
3
Inotuzumab Ozogamicin
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Cytarabine
3
Cyclophosphamide
3
tisagenlecleucel
2
pegaspargase
2
fish oil triglycerides
2
blinatumomab
2
In Situ Hybridization, Fluorescence
2
Imatinib Mesylate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Glucose Tolerance Test
×
Clear all
NCT03141398
2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn